• American City Business Journals3 days ago

    Valeant gets new approval for legacy Salix drug

    Embattled drug giant Valeant Pharmaceuticals International (VRX) heard some much-needed good news when the U.S. Food and Drug Administration approved a drug that has deep roots in Raleigh. Specifically, FDA approved Relistor tablets for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. The drug was a legacy product of Salix Pharmaceuticals, the Raleigh pharmaceutical company Valeant acquired in 2015.

  • TheStreet.com3 days ago

    Valeant's Drug Approvals May Save the Day

    Valeant could rake in more than $1 billion annually in new sales after FDA approval of a key drug.